Background. Staphylococcus aureus and Pseudomonas aeruginosa are key bacterial pathogens of the respiratory tract in patients with cystic fibrosis (CF). Although P. aeruginosa chronic bronchial infection is associated with a poorer prognosis, the consequences of S. aureus colonization on CF outcomes are controversial.
information on when and how to treat patients with positive S. aureus respiratory culture.
Because the predisposing role of S. aureus in the progression of lung disease is still being debated, no internationally accepted guidelines have been defined for treatment of MSSA or MRSA. This controversy stems from findings that treatment of S. aureus may lead to an earlier and enhanced acquisition of P. aeruginosa [9] [10] [11] .
The issues relative to CF pathogenesis deserve further model-based investigation to fill the gaps in the human studies. Murine models of long-term chronic infections have been previously established to mimic P. aeruginosa pathogenicity [7, 12] , whereas models showing the interaction between different pathogens during a respiratory infection are still in their infancy. As a result, the cascade of events, mediated by S. aureus and P. aeruginosa persistence in the pathogenesis of chronic airways infection, has not yet been addressed.
In this study, we describe further development of the model reported by Cigana et al [7] to clarify (1) whether and how S. aureus can be considered to be an independent contributor to CF lung disease pathogenesis, and (2) whether and how it impacts the progression of P. aeruginosa chronic lung infection, or not. We report that (1) in murine airway diseases, S. aureus promotes severe lesions-including abscess formation, (2) S. aureus increases the risk of subsequent chronic P. aeruginosa respiratory infection, and (3) once the chronic infection has been established, P. aeruginosa influences most of the inflammatory responses, independent of S. aureus.
MATERIAL AND METHODS

Ethics Statement
Animal studies adhered strictly to the Italian Ministry of Health guidelines for the use and care of experimental animals (protocol no. 738).
Bacterial Strains
For S. aureus, human clinical isolates USA300 [13] , SH1000 [14] , and Newman [15] were used. For P. aeruginosa, reference strain PA14, and clinical isolates AA2 and AA43 from a CF patient previously described [7, 16] were used. AA43 was collected 7.5 years after the acquisition of clonal AA2 isolate and before patient's death. Bacterial strains were cultured in trypticase soy broth and plated on mannitol salt agar for S. aureus and Pseudomonas isolation agar for P. aeruginosa.
Mouse Model
C57BL/6NCrl (B6) male mice (Charles River), 8-10 weeks old, were infected under anesthesia according to the previously described method [17, 18] . In brief, a 50-µL inoculum of an agar bead suspension containing 1-2 × 10 6 colony-forming units (CFUs) for S. aureus bacteria or empty beads was implanted via a 22-gauge cannula through the trachea into the lung, with all lobes inoculated. After 7 days from S. aureus chronic infection, mice were inoculated with an agar bead suspension containing 1-2 × 10 6 CFUs for P. aeruginosa bacteria or with empty beads for additional 14 days. Additional details are reported in the Supplementary Data.
Bronchoalveolar Lavage Fluid and Lung Processing, Cytokine/Chemokine
Quantification, and Histological Analysis After 7, 13, or 21 days from the first challenge, the bronchoalveolar lavage (BAL) was performed as described previously [17, 18] . Total cells present in the BAL fluid (BALF) were counted, and a differential cell count was performed on cytospins stained with Diff Quick. Lungs were removed and homogenized. The BALF and lung serial dilutions were plated on selective media for CFU count. Recovery of more than 1000 CFU of bacteria from lung cultures was indicative of chronic infection [16] . Lung homogenates were centrifuged, and the supernatants were analyzed by Bioplex (Bio-Rad). Histopathology was performed according to standard procedures. Sections of murine lungs were stained by anti-CD3 monoclonal antibody (mAb) or anti-F4/80 mAb; hematoxylin and eosin, Masson's trichrome (MTS), and immunofluorescence (IF) staining were examined blindly and scored by a pathologist, as detailed in the Supplementary Data.
Statistics
Statistics were performed with GraphPad Prism. Data analysis was performed using a non-parametric 2-tailed Mann-Whitney U test for single comparison or a non-parametric Kruskal-Wallis test followed by a post hoc Dunn test to correct for multiple comparisons, for CFU counts, histopathological scoring, cellular counts, and cytokine/chemokines quantification. MantelCox test was used to compare survival curves. Incidences of mortality and chronic colonization were compared using Fisher exact test. Two-way analysis of variance with Bonferroni's multiple comparison test was used to compare changes in body weight. P < .05 was considered significant.
RESULTS
Chronic Persistence of Staphylococcus aureus Promotes Airway Tissue
Damage in Mice
To study the long-term chronic infection and track the host response to S. aureus infection, we established a chronic infection (by agar bead-embedded bacteria) in C57BL/6NCrl (B6) mice with the reference clinical isolates USA300, SH1000, and Newman. All mice infected with USA300 were evidently sick (with considerable loss of body weight, scruffy coat, and inactivity), and high mortality was observed within 4 days postinfection ( Figure 1A-C) . Most of the mice infected with SH1000 and Newman lost less body weight, showed better clinical conditions compared with USA300, and established a nonlethal chronic colonization. At 13 days, the incidence of chronic colonization did not differ between SH1000 (80%) and Newman (87.5%) ( Figure 1C and Supplementary Table 1S) , and lung bacterial loads (SH1000 median: 2.9 × 10 6 CFU/lung; Newman median: 2.6 × 10 5 CFU/lung) ( Figure 2A ) did not differ significantly.
We performed a time-course analysis where mice were sacrificed 7, 13, and 21 days following Newman infection and analyzed for bacterial loads, cell recruitment in the BALF, and cytokines/chemokines. Overall, the incidence (%) of chronic colonization remained stable ( Figure 1C and Supplementary Table 1S), whereas bacterial loads decreased significantly at 13 and 21 days compared with 7 days. However, bacterial counts were stable from day 13 onwards until day 21. Leukocytes in the BALF, harvested at 7 days, decreased significantly at 21 days ( Figure 2B ) after bacterial loads (Figure 2A ). The levels of several cytokines/chemokines were significantly higher in mice retaining infection with Newman after 7 days, but their levels decreased to basal levels over 21 days (Table 1) .
Histopathological analysis 7 days postinfection with Newman revealed an initial formation of abscess-like lesions: these had increased further by 21 days ( Figure 2C) . A central necrotic zone, surrounded by a layer of CD3 + lymphocytes and macrophages and small amounts of fibrin/collagen, was observed with most of the staphylococci sequestered within necrotic lesions. Therefore, S. aureus shows an ability to establish long-term chronic pulmonary infections, promoting severe lesions in our murine model.
Staphylococcus aureus Preinfection Influences the Pathogenicity of
Pseudomonas aeruginosa
Next, we exploited the mouse model of S. aureus chronic lung infection to evaluate whether and how the staphylococcal infection impacts the subsequent superinfection with P. aeruginosa (Supplementary Figure 1S) . A reference P. aeruginosa strain (PA14), a clinical isolate (AA2) equipped with virulence factors, and its adapted variant (AA43) [16, 19] from a CF patient were used. Although PA14 and AA2 isolates express a wide series of virulence factors including swimming motility, twitching motility, and protease secretion [16, 20] and induce high mortality in mice, the CF-adapted AA43 isolate is mucoid and can establish long-term chronic infection [7, 16] .
We observed that the P. aeruginosa superinfection did not affect the high incidence of chronic infection established by S. aureus Newman strain. Instead, preinfection with S. aureus Newman strain significantly decreased the incidence of mortality induced by P. aeruginosa PA14 and AA2 strains and significantly increased the capacity of PA14 and CF-adapted AA43 strains ( Figure 3A and Supplementary Table 1S) to establish chronic infection. Although S. aureus impacted P. aeruginosa superinfection in terms of the incidence of mortality and chronic colonization, S. aureus and P. aeruginosa did not affect each other Table 1S . Statistical significance is indicated: **, P < .01; ***, P < .001; ****, P < .0001.
in terms of bacterial burden in the lung. Overall, pulmonary P. aeruginosa loads were similar in mice, preinfected or not with S. aureus ( Figure 3B ). However, it should be noted that the bacterial burden of S. aureus was higher than that of P. aeruginosa, independent of the strain used. Overall, these results indicate that S. aureus infection influences the pathogenicity of P. aeruginosa.
Pseudomonas aeruginosa Influences Most of the Inflammatory Responses
Independent of Staphylococcus aureus at a Late Stage of Chronic
Infection
The host response was then investigated in BALF (Supplementary Figure 2S ) and total lung (Figure 4 ) after long-term chronic infection. We assigned histopathological scores to quantify inflammation severity, immune cells recruitment, and the formation of bronchus-associated lymphoid tissue (BALT)-like structures at 21 days ( Figure 4 ). All conditions were scored except those with high mortality rate (PA14 and AA2 alone). The persistence of S. aureus resulted in a low level of inflammatory response, including infiltration of innate and adaptive immune cells both at bronchial and interstitial level (Supplementary Figure 2S and Figure 4 ). Subsequent infection with P. aeruginosa induced significantly higher inflammation and, in particular, higher infiltration of innate and adaptive immune cells, the latter organized in BALT-like structures when compared with S. aureus alone. In addition, preinfection with S. aureus did not affect the inflammatory response by the CF-adapted variant AA43 strain, further ascribing a greater role in lung injury to P. aeruginosa infection rather than to S. aureus. When measuring pulmonary cytokines/chemokines, we found that several of them were expressed at low levels in the lungs of both S. aureusor P. aeruginosa-infected mice (Table 1) , likely reflecting the attenuation of the host response in the late phase of chronic infection as previously observed [7] . Histopathology and IF staining for S. aureus and P. aeruginosa on day 21 localized the two bacterial species in different areas of the lung ( Figure 5 ). P. aeruginosa infection was localized mainly in the agar beads in bronchial lumens, but small colonies were also present in the parenchyma. S. aureus was localized primarily in the abscesses and rarely in the agar beads. Infection with P. aeruginosa yielded higher recruitment of innate immune cells, including neutrophils and macrophages, at both bronchial and parenchymal levels; the preinfection by S. aureus caused severe abscess-like lesions. These abscesses were characterized by large clusters of staphylococci surrounded by a massive number of immune cells, macrophages, and small amounts of fibrin/collagen.
DISCUSSION
Whether S. aureus infection contributes to lung pathogenesis and has an impact on early P. aeruginosa infection is still an open question. Clinical data are difficult to interpret due to the large number of confounding variables. In this investigation, we adopted the agar-beads model of infection that is well established for other pathogens [7] , to investigate the role of S. aureus in the long-term chronic lung infection. Our results indicate that S. aureus infection represents a risk factor for initial P. aeruginosa airway infection and has a role in the pathogenesis of the lung disease.
Three S. aureus strains of different origins and from different clinical settings were used to establish the model of long-term chronic infection. We found that USA300, a community-associated MRSA, causes acute infection, whereas the MSSA strains SH1000 and Newman can establish chronic persistent infection. S. aureus reference isolates (SH1000 and Newman) showed a remarkable capacity to induce chronic pneumonia, supporting our previous report with a panel of clinical CF strains [21] . Of interest, two S. aureus reference isolates of this paper and six clinical CF strains of our previous study [21] , including those sampled at the onset of chronic colonization and after years of chronic infection, did not differ in their pathogenicity. All isolates showed significant ability to induce chronic pneumonia with high bacterial loads in the murine lung, severe lesions in bronchi, and pulmonary parenchyma. The only exception was the highly invasive and PVL-producer MRSA-USA300 [13] that induces severe sepsis, as previously observed in other models [22] , rather than long-term chronic pulmonary infection. Several European studies tracked the persistence of S. aureus among CF patients over extended periods of time [23] [24] [25] . In most patients, long-term colonization by S. aureus occurred, indicating a persistence capacity similar to P. aeruginosa. CF patients with high S. aureus density in throat cultures experience a more rapid lung function decline [25] , and bacterial persistence has an impact on bacterial adaptation but with no uniform adaptive changes in isolates of the same clonal lineage in different patients and no clear impact on pathogenesis [21] . Staphylococcal respiratory infection in CF patients is rarely associated with bacteremia, and the formation of abscesses has been reported only in a few cases with PVL + MRSA infections [26] . However, in several non-CF clinical conditions, abscesses have been documented in numerous different organ tissues. In our murine model, long-term persistence of S. aureus in the lungs induced regional abscesses characterized by large clusters of staphylococci surrounded by massive numbers of immune cells, macrophages, and small amounts of fibrin/collagen. These severe lesions were confined to a limited region in the parenchyma. When the total lung was scored for levels of inflammation, it was observed that the infiltration of innate and adaptive immune cells was largely limited to the abscesses. Therefore, in our murine model, MSSA S. aureus can form the lung abscesses as described for different organs in other models of infection [27] . It remains to be established whether abscess formation in the lung is a feature of the murine model or whether further studies in patients with CF are necessary. Table 1S . Statistical significance is indicated: *, P < .05; **, P < .01; ***, P < .001.
Next, we compared these results to the mouse model of P. aeruginosa [7] . Direct comparison between S. aureus and P. aeruginosa in single infections showed that S. aureus is difficult to eradicate by the host and is more efficient in establishing a chronic infection with higher bacterial load and percentage of chronicity than P. aeruginosa in the murine model [16] . These findings support the hypothesis that, in some ways, S. aureus has higher pathogenicity compared with P. aeruginosa. We were surprised to find that the host immune response was limited to the areas of the abscesses compared with the diffused P. aeruginosa inflammation.
In humans, there is conflicting evidence for the role of S. aureus in lung disease in CF patients and, consequently, for the clinical impact of anti-staphylococcal therapy. Observational studies have identified relationships between S. aureus detection and lower lung function [28] or higher inflammation [25, 29] . On the other hand, other studies found S. aureus to be associated with better survival [30] and better lung function [31] . Based on our results using an animal model of chronic lung infection, we support the notion that S. aureus infection is asymptomatic based on specific clinical signs (eg, recovery of body weight and general health evaluation), were performed on slices stained with H&E. The data are pooled from at least 2 independent experiments (n = 3-6). Values represent the mean ± standard error of the mean. Statistical significance is indicated: *, P < .05; **, P < .01; ***, P < .001.
whereas it can induce severe damage confined to parts of the lung that is difficult to resolve, as revealed by histopathology. S. aureus is often reported as being the first pathogen infecting the lungs of the CF patients, followed by P. aeruginosa. Although the 2 organisms are frequently co-isolated in clinical specimens, several studies demonstrated that S. aureus and P. aeruginosa have a competitive interaction [32] . Previous studies showed that when cocultured, P. aeruginosa thrives better than S. aureus [33] . The better survival of P. aeruginosa is attributed to its ability to produce respiratory toxins such as pyocyanin, hydrogen cyanide, and alkyl-hydroxyquinoline N-oxides that can block the electron transport pathway, thereby inhibiting the growth of S. aureus and other pathogenic staphylococci [34, 35] . A prolonged growth of S. aureus with P. aeruginosa may select for S. aureus SCVs altering the population structure of bacterial communities [36] , but SCVs have not been detected in our animal model. Using a collection of longitudinal strains isolated from CF patients, we previously showed that P. aeruginosa strains outcompeted S. aureus [37] . This effect was associated with P. aeruginosa early isolates, which in acute infection present higher virulence. On the contrary, P. aeruginosa late CF-adapted isolates showed reduced or abolished capacity to outcompete S. aureus. Findings in this work expand previous data. In this study, we used the agarbeads mouse model of long-term chronic infection approaching the advanced stage of chronic pneumonia and adopting an experimental design to mimic subsequent infection that occurs in CF patients. Our results did indicate that S. aureus and P. aeruginosa coexist in the mouse lungs without interfering with each other. These observations, different from the previous models of acute infection and in vitro data, could be influenced by the experimental design and the environmental conditions. The microanaerobic growth conditions for bacteria created by agar-beads may change bacterial virulence factors that affect the pathogenesis [38] . Furthermore, we demonstrated that S. aureus precolonization represents a risk factor for initial P. aeruginosa airway infection as documented by the increasing capacity to establish chronic infection of several P. aeruginosa strains. S. aureus may cause lesions and patho-physiological changes in the infected lungs that pave the way for P. aeruginosa colonization. The severity of these lesions may suggest that even if eradication of S. aureus was possible, it might not be sufficient to restore the lung physiology. Furthermore, preinfection with S. aureus decreased the incidence of mortality induced by P. aeruginosa. The motile P. aeruginosa strains can easily disseminate from the lung to the blood by provoking epithelial injury. It may be possible that the infiltrating immune cells induced by previous S. aureus infection can block the P. aeruginosa spreading from lung to blood.
In patients with CF, P. aeruginosa is the leading pathogen that marks the transition to the fatal, chronic stage of the infection. Our model was instrumental in demonstrating the substantial contribution of P. aeruginosa when preceded or not by S. aureus. Overall, P. aeruginosa persistence had a greater effect on inflammation and damage compared with S. aureus. When we investigated S. aureus/host interaction and/or P. aeruginosa/ host interaction in mice in detail, two distinct pathogenic profiles emerged. Although S. aureus infected the airways and was then confined in abscess-like lesions in the parenchyma, P. aeruginosa was mainly localized in bronchial lumens. S. aureus and P. aeruginosa infections showed different capacities in shaping the host immune response. P. aeruginosa stimulates a much stronger host inflammatory response compared with S. aureus. Once the chronic infection has been established, P. aeruginosa influences most of the inflammatory responses, independently of S. aureus. Coinfection with the two pathogens does not result in an additive effect but rather a follow-on of the P. aeruginosa response. The observation supports the hypothesis of long-lasting pathological consequences of P. aeruginosa infection.
CONCLUSIONS
The results presented in this study have real importance to understanding CF airways disease pathogenesis and progression. Our study clearly emphasizes the role of S. aureus as a bacterium with high pathogenic potential that enhances P. aeruginosa pathogenesis to different extents. To further explore our findings, a panel of different S. aureus and P. aeruginosa strains, including sequential isolates from CF patients, should be tested in the mouse model. So far, our observations underline the need to assess different strategies to treat S. aureus infection in CF patients.
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